AATB is issuing this Bulletin to update and clarify information that was provided in Bulletin 23-2, published on May 8, 2023, related to the current critical supply issue for a specific anti-HIV-1 and 2 licensed donor screening assay.

The AATB Council Members form a cohesive community, actively propelling progress in our industry. This dedicated group of individuals harnesses their expertise and insights to propel the association's mission forward. Discover the endeavors undertaken by these groups in the past quarter and get involved in the excitement.

Whether you're a scientific mastermind or an administrative superstar, we want to hear from you! AATB is seeking submissions in both categories, giving you a chance to highlight your contributions to tissue banking across all disciplines. Don't miss the opportunity to showcase your groundbreaking tissue banking research at the 2023 Annual Meeting! With a prime location in the stunning National Harbor, MD, this year's event is the perfect platform to gain recognition and acclaim for your hard work. The deadline for abstract submissions is May 26, so submit your work today!

Nominations are now being accepted for the 2023 AATB Achievement Awards. The annual AATB Achievement Awards are a great opportunity to honor exceptional individuals within the tissue banking community. The awards to be presented include the Jeanne C. Mowe Distinguished Service Award, the George W. Hyatt Memorial Award, and the Kenneth W. Sell Memorial Award. To learn more about each award, the submission criteria, and how to submit your nomination, please visit our website. The deadline for all nominations is May 31, 2023. Join us in celebrating excellence in tissue banking by nominating deserving individuals.

The Unified Rule Making Agenda includes the following, originally listed for potential release on May 1, 2023: HCT/Ps that are regulated solely under section 361 of the Public Health Service Act and the regulations in 21 CFR part 1271 (“361 HCT/Ps”) are not regulated under the FD&C Act. As a result, FDA’s statutory authority under section 704(a)(4) of the FD&C Act to request records or other information in advance of or in lieu of a drug establishment inspection does not apply to these products. Currently, FDA can request that establishments submit records voluntarily in advance of or in lieu of an inspection for 361 HCT/Ps but cannot require that HCT/P establishments provide such records. The proposed amendment would establish requirements for the submission of records or other information to FDA upon request, in advance of or in lieu of an inspection of establishments that manufacture 361 HCT/Ps and require the participation in a remote interactive evaluation of such establishments, upon request by FDA.

Join us September 17-20 at the Gaylord National Resort & Convention Center in National Harbor, MD, for the 2023 AATB Annual Meeting. Registration opens in June.

The AATB Annual Meeting brings together the most talented and knowledgeable individuals in the tissue banking field for valuable networking, training, and collaborative opportunities that cannot be found elsewhere. Participate in this event to exhibit your products and services, connect with attendees on a personal level, and share your expertise. Don't miss the chance to sponsor and showcase your offerings at the 2023 AATB Annual Meeting - sign up now!

Nature
For a dying cell to undergo pyroptosis or apoptosis, it requires the cell-surface protein NINJ1, so inhibiting this protein is a potential target for therapies.

Northeastern Global News
A company focused on the therapeutic potential of collagen believes the protein can be used to treat muscle injuries in half the time.

Communications Biology
Researchers used a physics-informed neural network algorithm to infer 3D flow-induced tissue dynamics from 2D images.

Science News
MIT engineers have developed tissue-derived 'smart' sutures coated with hydrogels embedded with sensors, drugs, or cells that release therapeutic molecules.

Cancer Network
An investigation found that intravenous delivery of doxorubicin for patients with soft-tissue sarcomas does not improve outcomes compared with bolus delivery.

Join AATB and Grace Bolton, CEO and Founder of QVEX Consulting, LLC, on May 31 for an overview of the critical elements to consider to ensure that a process being implemented can produce allografts that are processed consistently while meeting predetermined specifications.

Join us June 1 for the first webinar in the FREE Donation & Death Investigation Webinar Series. This webinar, "Supporting our Shared Mission: Guide to Medical Examiner & Coroner Cases," features expert speakers Jonathan Boyd, Kristen McCoy, Kelly Keyes, and Brian Bricker. During this webinar, you will learn how collaborative initiatives between organizations representing the fields of donation and death investigation can improve the outcome of shared cases and support the needs of the medicolegal community.

We invite you to a FREE webinar developed in collaboration with the American Society for Transplant Surgeons. In this June 13 session, we will explore strategies for surgeons to safeguard the possibility of heart valve donation during organ recovery, ultimately increasing access to this life-saving treatment. Don't miss out - register now to secure your spot in this informative session!